(Q37729183)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Emerging medical treatment for angina pectoris (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Anwar Tandar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

William E Boden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Emerging Drugs

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

283-298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

William Heberden and Some Account of a Disorder of the Breast.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Characteristics of a contemporary population with angina pectoris. TIDES Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

A novel ras-related gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Rho-kinase inhibition in the therapy of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of Perhexiline on Coronary Hemodynamic and Myocardial Metabolic Responses to Tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Inhibitory effects of some cyclohexylaralkylamines related to perhexiline on sodium influx, binding of [3H]batrachotoxinin A 20-α-benzoate and [3H]nitrendipine and on guinea pig left atria contractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Inhibition of HERG channels stably expressed in a mammalian cell line by the antianginal agent perhexiline maleate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Metabolic therapeutics in angina pectoris: history revisited with perhexiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Ranolazine: a novel agent that improves dysfunctional sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Nicorandil associated anal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Nicorandil may be associated with gastrointestinal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Energetics in the pathogenesis of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Mitochondrial genome instability in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Multiple inhibitory effects of zatebradine (UL-FS 49) on the electrophysiological properties of retinal rod photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Action of the hyperpolarization-activated current (Ih) blocker ZD 7288 in hippocampal CA1 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Rho kinase, a promising drug target for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Impact of body mass index on outcomes of enhanced external counterpulsation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Long-term results following percutaneous myocardial laser therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Therapeutic angiogenesis: a biologic bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903544482

Trimetazidine for stable angina

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003614.PUB2

Identifiers

DOI

10.1517/14728210903544482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20384546%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference